Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Cell Culture Reagents Market size was over USD 5.94 billion in 2024 and is poised to exceed USD 28.11 billion by 2037, growing at over 12.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cell culture reagents is evaluated at USD 6.58 billion.
Extensive research associated with various diseases and treatments in western countries, along with the growing investment in the development of advanced therapies are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing research in vaccine development and rising research in stem cell technology. It indicates there is a need of vaccine development. Moreover, the market for cell culture reagents is mainly driven by biotechnology sector. Increasing awareness about stem cell culture is likely to be major factor for cell culture reagents market. In addition, cell culture reagents are also used in medicine, microbiology, agriculture, pharmaceuticals, food additives and cosmetics. Increasing demand for advanced technologies from biopharmaceuticals is likely to provide opportunities for cell culture reagents market in near future. The growth of the market can be attributed to the fact that cell culture reagents play a key role in cell-based products, manufacturing and testing of pharmaceutical drug products, and several other healthcare-related solutions. Technological advancements in pharmaceutical and biotechnology sector are expected to be major drivers for the market. However, threats from the substitutes and higher prices can be major restraint for the market.
Cell Culture Reagents Sector: Growth Drivers and Challenges
Growth Drivers
- Funding for cell-based research
- Rise in biopharmaceutical research
Challenges
- High cost of cell biology research
Cell Culture Reagents Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
12.7% |
|
Base Year Market Size (2024) |
USD 5.94 billion |
|
Forecast Year Market Size (2037) |
USD 28.11 billion |
|
Regional Scope |
|
Cell Culture Reagents Segmentation
The cell culture reagents market is segmented based on reagent type into media, sera, culture, and others, out of which, the culture segment is anticipated to grab the largest share by the end of 2025. The primary reason behind the major share of culture segment is the application of mammalian cell cultures in the production of mammalian pharmaceuticals and the growing demand for non-conventional drugs developed as a result of bio-production of proteomically and genetically enhanced drugs. This segment is expected to witness lucrative growth in demand over the forecast period.
On the basis of application, the biopharmaceutical manufacturing segment in the global cell culture reagents market is projected to grow with a significant CAGR over the forecast period. This segment's high growth is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and an increase in the demand for monoclonal antibodies (mAbs).
Our in-depth analysis of the global market includes the following segments
|
By Reagent Type |
|
|
By Applications |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportCell Culture Reagents Industry - Regional Synopsis
APAC Market Statistics
Asia Pacific industry is predicted to hold largest revenue share by 2037, owing to increasing demand for cell culture media and rise in biopharmaceutical research, owing to increasing demand for cell culture media and rise in biopharmaceutical research.
North America Market Analysis
Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue. The growing regulatory approvals for cell culture-based vaccines, growing academic and government investments in cell-based research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America are driving the cell culture market in the region.
Companies Dominating the Cell Culture Reagents Landscape
- Becton, Dickinson and Co.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Techne Corp.
- FUJIFILM Irvine Scientific, Inc.
- Cytiva Life Sciences
- Fluidigm Corp.
- GE Healthcare
- Lonza Group Ltd.
- Merck KGaA
- Sartorius AG
- Thermo Fisher Scientific Inc.
In the News
- April 2021: Thermo Fisher Scientific announced on April 15, 2021 that it has acquired PPD, a clinical research services provider, for $17.4 billion. The collaboration is expected to offer new solutions for customers, while reducing the time and cost of the drug development process.
- April 2021: Bio-Techne announces launch of professional assay services - dedicated source for RNA in situ hybridization assays in spatial gene expression analysis.
- March 2019: Cytiva announced a digital data exchange collaboration program with Amgen, which will include advanced data analytics to increase the understanding of the relationship between raw material variability and process performance during the manufacture of biologic medicines.
Author Credits: Radhika Pawar
- Report ID: 3161
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT
